• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . False-negative results of initial RT-PCR assays for COVID-19: A systematic review

tetano

Editor, Senior Moderator
PLoS One


. 2020 Dec 10;15(12):e0242958.
doi: 10.1371/journal.pone.0242958. eCollection 2020.
False-negative results of initial RT-PCR assays for COVID-19: A systematic review


Ingrid Arevalo-Rodriguez[SUP] 1 2 [/SUP], Diana Buitrago-Garcia[SUP] 3 4 [/SUP], Daniel Simancas-Racines[SUP] 5 [/SUP], Paula Zambrano-Achig[SUP] 6 [/SUP], Rosa Del Campo[SUP] 6 [/SUP], Agustin Ciapponi[SUP] 7 [/SUP], Omar Sued[SUP] 8 [/SUP], Laura Martinez-Garc?a[SUP] 2 6 [/SUP], Anne W Rutjes[SUP] 3 4 [/SUP], Nicola Low[SUP] 3 4 [/SUP], Patrick M Bossuyt[SUP] 9 [/SUP], Jose A Perez-Molina[SUP] 10 11 [/SUP], Javier Zamora[SUP] 1 2 12 [/SUP]



Affiliations

Abstract

Background: A false-negative case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is defined as a person with suspected infection and an initial negative result by reverse transcription-polymerase chain reaction (RT-PCR) test, with a positive result on a subsequent test. False-negative cases have important implications for isolation and risk of transmission of infected people and for the management of coronavirus disease 2019 (COVID-19). We aimed to review and critically appraise evidence about the rate of RT-PCR false-negatives at initial testing for COVID-19.
Methods: We searched MEDLINE, EMBASE, LILACS, as well as COVID-19 repositories, including the EPPI-Centre living systematic map of evidence about COVID-19 and the Coronavirus Open Access Project living evidence database. Two authors independently screened and selected studies according to the eligibility criteria and collected data from the included studies. The risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. We calculated the proportion of false-negative test results using a multilevel mixed-effect logistic regression model. The certainty of the evidence about false-negative cases was rated using the GRADE approach for tests and strategies. All information in this article is current up to July 17, 2020.
Results: We included 34 studies enrolling 12,057 COVID-19 confirmed cases. All studies were affected by several risks of bias and applicability concerns. The pooled estimate of false-negative proportion was highly affected by unexplained heterogeneity (tau-squared = 1.39; 90% prediction interval from 0.02 to 0.54). The certainty of the evidence was judged as very low due to the risk of bias, indirectness, and inconsistency issues.
Conclusions: There is substantial and largely unexplained heterogeneity in the proportion of false-negative RT-PCR results. The collected evidence has several limitations, including risk of bias issues, high heterogeneity, and concerns about its applicability. Nonetheless, our findings reinforce the need for repeated testing in patients with suspicion of SARS-Cov-2 infection given that up to 54% of COVID-19 patients may have an initial false-negative RT-PCR (very low certainty of evidence).
Systematic review registration: Protocol available on the OSF website: https://tinyurl.com/vvbgqya.
 
Back
Top Bottom